LOL, you and me both. I saw it posted on ihub and
Post# of 72440
Posted On: 03/01/2013 5:39:04 PM
LOL, you and me both. I saw it posted on ihub and hopped on the company website thinking it was a short PR. Nothing there so i checked my email and there it was via email alert. At first i thought it was just someone having some fun posting something they wish would happen. This is very interesting, i am still trying to digest it, but sloan kettering...another top notch institution involved with CTIX,
Not to mention anything from Danishefsky has to be promising to say the least. Here is his background info:
Dr. Samuel Danishefsky, Scientific Advisor
Dr. Samuel Danishefsky is an internationally recognized leader in chemistry, specializing in the synthesis of biologically active organic compounds. He is regarded as one of the world’s leading chemists in cancer research. Dr. Danishefsky earned his Ph.D. in chemistry from Harvard. He spent 14 years at Yale University, where he rose to the rank of Sterling Professor of Chemistry, the highest academic rank at Yale University, awarded to a tenured faculty member considered one of the best in his or her field. By 1991, he was also sharing his time with Memorial Sloan-Kettering Cancer Center as director of the Laboratory for Cancer Research Bioorganic Chemistry, becoming chair in 1993. He accepted an appointment as professor at Columbia University in 1993, and now conducts research at both institutions.
Not to mention anything from Danishefsky has to be promising to say the least. Here is his background info:
Dr. Samuel Danishefsky, Scientific Advisor
Dr. Samuel Danishefsky is an internationally recognized leader in chemistry, specializing in the synthesis of biologically active organic compounds. He is regarded as one of the world’s leading chemists in cancer research. Dr. Danishefsky earned his Ph.D. in chemistry from Harvard. He spent 14 years at Yale University, where he rose to the rank of Sterling Professor of Chemistry, the highest academic rank at Yale University, awarded to a tenured faculty member considered one of the best in his or her field. By 1991, he was also sharing his time with Memorial Sloan-Kettering Cancer Center as director of the Laboratory for Cancer Research Bioorganic Chemistry, becoming chair in 1993. He accepted an appointment as professor at Columbia University in 1993, and now conducts research at both institutions.
(0)
(0)Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼